Wegovy is a medication typically prescribed for weight loss and cardiovascular risk reduction individuals with overweight or ...

Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

So, how does Victoza compare to other GLP-1 medications, including semaglutide or tirzepatide? Here’s what you need to know ...

Walking remains one of the most sustainable forms of exercise for adults trying to improve health and burn more calories.

But with GLP-1 drugs, she said, “everyone is kind of iterating in real time.” Here’s what we’ve learned in the process. At ...

Weight loss can seem like it comes with a list of dos and don’ts, making it overwhelming. Cardio is a particularly hot topic amongst weight loss experts, and if we’re being honest, the constant ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

June 9 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to capture a slice of a fast-growing sector dominated by Novo Nordisk and Eli Lilly. Analysts expect the ...

Face, stomach, hips, legs — where do you lose weight first? Unfortunately, there’s no solid answer to that. Women tend to lose weight in their legs first, while men are more likely to lose weight in ...

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they ...